the support from all sources of research to delay death fell to less than 3% of that figure. As a footnote I find it even more bizarre that with our continuing national fixation on what might be considered Earth Day ceremonies more money is spent on funerals than on medical research in the United States. Despite these exercises in comparative statistics the absolute size of the biomedical science budget will continue to stand as a tempting target for the unpersuaded.
In any consideration of pathogenesis we must also note that other pressing problems contend for support from finite federal resources. Although some of the more martial aspects of our foreign policy may be yielding minimal national gratifications and the supersonic transport may seem both boom and bust, there are other priorities which few would deny. These include poverty, the inner cities, education, the environment, population control, health care itself, and other variables which affect what now is called "the quality of life." The biomedical science budget is therefore competitive in good company as well as in bad and sometimes suffers in the ensuing tradeoffs for limited funds. some have a certain validity which must be recognized by a careful response. A few of these criticisms, which come both from within and without the profession, will be touched upon briefly. No one who is in medical education has escaped wholly the wave of anti-intellectualism which has appeared in our colleges and universities and now laps in an attenuated form into our medical schools. Although many of us might consider medicine to be effective to the degree that it is based firmly in a scientific foundation, this is not universally acclaimed by students today. Much of their concern for the immediate problems of society is highly commendable and will be increasingly reflected in our profession over the years ahead to the benefit of the nation. Unfortunately, this concern too often leads the medical neonate into an easy assumption of antipathy to the scientific basis of medical care. There emerges a Rousseau-like dream world of natural bonhomie, unencumbered by the rigors of molecular interactions, where everything is warm, moist, and relevant. This amniotic state of mind, although the byproduct of national trends, must give us concern for it is apparent in those who are our professional progeny. In my opinion, this rejection of science is a serious fallacy which calls for an answer throughout our educational system. A distinction can be made between maturation and growth. Superficial training in "relevant" clinical medicine without scientific insight may lead to early maturation as a physician but not to the capability for further growth. It is like giving thyroxine to a tadpole. One gets an instant frog, but unfortunately a rather small one. Stated obversely, science is necessary for the physician if his intellectual epiphyses are to remain open.
A second and more serious criticism with which we are confronted relates more directly to the outflow pathway from medical science to its final application in health care. Here two constrictions are envisioned, one of them between basic science and its investment in specific mission-oriented research on major health problems. The second is an alleged lack of concern about the distribution system of health care. In essence the thrust of this criticism is that the biomedical scientist pursues his research as an intellectual game, hermetically sealed off from the real problems of society, indifferent to the ultimate utility, or even lack thereof, of his discoveries. The spin-offs may be there but they come grudgingly from a process with a rather low angular velocity. This criticism, although not presented in sophisticated terms, must be taken seriously for it has been expressed directly or implied from positions of authority. It is also subject to action, and this has already been reflected in national policy in very tangible budgetary terms. In my opinion, the first part of this criticism is based on a lack of understanding concerning the mechanisms of scientific progress; the second part has a certain validity. We should differentiate between the two. Basic biologic and medical research has prospered in this country in recent years, judged by any standard of measurement. The ability for the average citizen to obtain prompt, effective medical care at a price he can afford has not kept pace, to state the problem as a euphemism. Our scientists flock to Stockholm each winter with admirable regularity; our infant mortality rate (now as widely publicized as the -GNP) slips to 14th in international competition. Life expectancy for males in the USA ranks 18th, and for females 11th, among countries which record vital statistics. In the mind of the public, this disparity is linked, simplistically and fuzzily but nevertheless dangerously, and it would be folly to ignore the implications.
The support of medical research, divorced from basic science, is a scenario for decline. The record is clear in the case histories of all major medical advances of the last generation. There are few in this audience who would dispute this particular generalization. Unfortunately, this interrelation of basic biology and medical progress is not so easily grasped by a utilitarian public, jaded by technical achievements and space spectaculars. The public may be ready to invest in the specific solutions to medical problems "of clear and present danger" (to use Justice Holmes' phrase), but the support of the broad base of biology as a legitimate national goal requires a level of sophistication which is hard to obtain and to sustain. This difficulty is reflected in many ways. We are asked to define what the proper mix should be in the support of basic vs. mission-oriented research as if these were alien and contending disciplines within impervious capsules, rather than a continuum of activity by the individual scientist and by science as a whole. Targets are being selected now, sometimes on dubious grounds, with diversion of resources during a period of declining over-all support. The defense of untargeted research is now and will continue to be one of our main problems. It will be difficult, but at least the profession can base its case on a positive record of accomplishment.
The second point of constriction between biomedical science and patient care finds us on shakier ground, that is, the crisis which is occurring in our health care system. Not only is the crisis growing, but its dimensions are becoming increasingly apparent to the public and even to the profession. In a sense most health care is ultimately derived from the academic medical centers. In its educational role, the academic center creates the profession; in its research role, it creates and perfects the tools of the profession. It might be considered to manufacture the basic commodity of its- This has been only a brief recitation of some of the problems which face us at this particular time of dwindling confidence in biomedical research and the erosion in financial and political support which has followed. What can we do in response to this challenge? There are no easy answers. We have a very broad audience in this country. The basic problem is to convert this audience to a supporting constituency. It will require clarification of our goals, education of the American public, and intimate knowledge of the mechanisms by which decisions are made in the federal government. Some of this can be accomplished individually through education of our friends, patients, colleagues, and our representatives in government. The latter is of particular importance and preferably carried out locally, for the receptivity of the individual congressman increases in a linear fashion as he returns to his constituency. Arguments which appear to be special pleading in Washington gain credence when encountered with specific details in a familiar setting. In addition, there are things which we must do collectively as members of a scientific community. In order to act in concert, it is necessary to form a more effective national organization to serve as a broad forum for the biomedical scientific community. The need for such a structure was presented before this Society last year by Dr. Arnold S. Relman in his eloquent Presidential Address and will not be elaborated upon now. The past 12 months have perhaps brought us closer to that goal, but the final pattern has yet to emerge. Whether this will come eventually as a National Academy of Medicine or in some marsupial arrangement with the American Association of Medical Colleges has not yet been established. Your officers have participated in these activities and will continue to do so over the months ahead.
In summary, the beginning of this new decade finds our science and our profession troubled by challenges from within and from without, and facing a period of retrenchment coming unexpectedly after an era of unparalleled success. Our response to that challenge may in large measure determine the future of biological science and scientific medicine in this country. It is a time which calls for Abbott Neckam's "sedulous diligence of labor" and "vehement application of mind" by each of us individually and from all of us collectively.
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